Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery

Authors:

Abstract
Using the EORTC Global Health Status (GHS) scale, we aimed to determine minimal clinically important differences (MCID) in health-related quality of life (HRQOL) changes for older cancer patients with a geriatric risk profile, as defined by the geriatric 8 (G8) health screening tool, undergoing treatment. Simultaneously, we assessed baseline patient characteristics prognostic for HRQOL changes.

This publication has 40 references indexed in Scilit: